arginine has been researched along with dapagliflozin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd Elmaaboud, MA; Arab, HH; Kabel, AM | 1 |
| Bosch, A; Fromm, MF; Gemeinhardt, A; Gessner, A; Kannenkeril, D; Maas, R; Mayr, A; Schmieder, RE; Staerk, C | 1 |
| Bae, E; Jo, HA; Kim, DJ; Kim, DK; Kim, YS; Lee, S; Seo, JH; Yang, SH; Yu, MY | 1 |
1 trial(s) available for arginine and dapagliflozin
| Article | Year |
|---|---|
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers.
Topics: Arginine; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome | 2022 |
2 other study(ies) available for arginine and dapagliflozin
| Article | Year |
|---|---|
Effect of dapagliflozin and/or L-arginine on solid tumor model in mice: The interaction between nitric oxide, transforming growth factor-beta 1, autophagy, and apoptosis.
Topics: Animals; Apoptosis; Arginine; Autophagy; Benzhydryl Compounds; Glucosides; Male; Mice; Neoplasms; Nitric Oxide; Transforming Growth Factor beta1; Transforming Growth Factors | 2021 |
Metabolomic profiling in kidney cells treated with a sodium glucose-cotransporter 2 inhibitor.
Topics: Arginine; Asparagine; Epithelial Cells; Glucose; Glutathione; Histidine; Humans; Isoleucine; Kidney; Lysine; Metabolomics; Methionine; Phenylalanine; Proline; Sodium; Sodium-Glucose Transporter 2; Threonine | 2023 |